A recent study concluded that hemorrhagic myocardial infarction (hMI) remains a common and clinically significant ...

Early substrate-based radiofrequency catheter ablation (RFCA) was associated with reduced risk of implantable cardioverter defibrillator (ICD) therapies, but with no meaningful difference ...

Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...

Key points A 56-year-old woman presented to the emergency department with a 2-day history of central chest pain and dyspnea. Her medical history included having had a myocardial infarction (MI) with n ...

A study finds target lesion failure in 1 in 5 patients with STEMI within 10 years of primary percutaneous coronary ...

Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables ...

Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...

Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...

AACE has updated the guidelines for dyslipidemia management, emphasizing pharmacotherapy to reduce ASCVD risk.

Shovelling snow is not only tiring but also can be dangerous for your heart. Research from Quebec, published in the Canadian ...

In a meta-analysis of individual patient data, patients with acute MI and multivessel coronary artery disease benefited from ...

Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...